In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex
Journal
Antimicrobial Agents and Chemotherapy
Journal Volume
63
Journal Issue
4
Pages
e02234-18
Date Issued
2019
Author(s)
Tsai Y.-T.
Chang S.-Y.
Abstract
Infections caused by the difficult-to-treat bacterium Mycobacterium abscessus are increasing in frequency. Rifabutin, in contrast to rifampin, appears to be active in vitro against M. abscessus , especially against clarithromycin-resistant strains.
SDGs
Publisher
American Society for Microbiology
Type
journal article